A comprehensive view of Biopharmaceuticals / Biologics. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.
INTERNATIONAL PATENT: ELI LILLY AND COMPANY FILES APPLICATION FOR "METHODS AND SYSTEMS FOR USING CAUSAL NETWORKS TO DEVELOP MODELS FOR EVALUATING BIOLOGICAL PROCESSES"
Published:
April 23, 2024
by U.S. Fed News
|
INTERNATIONAL PATENT: THE GENERAL HOSPITAL CORPORATION, MASSACHUSETTS EYE AND EAR INFIRMARY, BANNER HEALTH FILES APPLICATION FOR "COMPOSITIONS AND METHODS USING REELIN IN ALZHEIMER'S DISEASE"
Published:
April 23, 2024
by U.S. Fed News
|
INTERNATIONAL PATENT: ELI LILLY AND COMPANY FILES APPLICATION FOR "APPARATUSES FOR AND METHODS OF CONCENTRATING BIOMOLECULES"
Published:
April 23, 2024
by U.S. Fed News
|
INTERNATIONAL PATENT: THE BROAD INSTITUTE, INC., BIOGEN MA INC. FILES APPLICATION FOR "GLYCOGEN SYNTHASE KINASE 3 INHIBITORS AND USES THEREOF"
Published:
April 23, 2024
by U.S. Fed News
|
Amgen reports it has successfully implemented a hybrid continuous manufacturing process for a commercial lifecycle program; the process has potential to reduce costs and increase efficiency in the biotech industry
Published:
April 22, 2024
by Biotech Business Daily
|
Ask us about our Government & Public Policy market view